GLP-1 receptor dual agonists GIP and GCG which are involved in nutrient and energy metabolism, can be one of the components of these multi-functional single molecules
Unlike the brand-name drugs Ozempic, Wegovy, Mounjaro, and Zepbound, compounded versions havent been rigorously tested in clinical trials, and theyre not approved by the Food and Drug Administration
Current clinical trials indicate: Most side effects are mild to moderate Many occur during dose escalation rather than long-term treatment Gastrointestinal symptoms are by far the most frequently reported Serious adverse events remain relatively uncommon Not everyone experiences adverse effects
We used Endnote (Endnote 21) software to manage references, identify duplicate records, and remove them
But when in doubt, pinch
Always check suitability with a healthcare professional if you are unsure